Important Medical Disclaimer

Welcome to Dr. Woods' Peptide Research Portal. Before entering, please review and acknowledge the following:

  • This portal is strictly for educational and research purposes only.
  • None of the information presented here constitutes medical advice, diagnosis, or treatment.
  • The research, clinical trials, and literature linked within this portal are for scientific exploration and do not endorse any specific therapy.
  • Always consult with a qualified, licensed physician before considering or initiating any peptide or longevity protocol.

By clicking "I Agree & Enter", you acknowledge that you are accessing this information for educational purposes and release Elevate-HER and its contributors from any liability.

⚠️ MEDICAL DISCLAIMER: For educational and research purposes only. Not medical advice. Consult a physician before any protocol.

Dr. Woods' Peptide Research Portal | Elevate-HER

Access key primary literature and discover therapeutic breakthroughs.

Foundational Peptides

Core research and establishing principles in peptide therapy.

Start Here: The Language of Cells Primer

Your cells are constantly talking to one another. Before exploring specific compounds, start with Dr. Woods' foundational masterclass: Speaking the Language of Cells. This 14-page visual guide explains how to move from passively treating symptoms to becoming the architect of your own biology. Learn the core mechanisms, delivery methods, and the science behind aging, repair, and vitality.

Beginner Research Pathway

Click to reveal detailed, beginner-friendly instructions.

In Plain English: Peptides are short chains of amino acids that act as your body's native signaling language. Because our natural production of these vital messengers drops as we age, targeted peptide therapy is becoming a cornerstone of proactive health. By binding to specific cellular receptors, they trigger precise actions like reducing inflammation, stimulating healing, or balancing the immune system. In fact, popular medications like Ozempic demonstrate just how powerful and mainstream peptide therapies have become.

Peptides are the body's native signaling language. These short chains of amino acids bind to specific cellular receptors to trigger precise biological actions - from reducing inflammation and stimulating growth hormone release to modulating the immune system. Because our natural endogenous peptide production declines significantly as we age, targeted exogenous peptide therapy is becoming a cornerstone of proactive health. In fact, some of the most widely recognized and FDA-approved medications on the market today - such as the GLP-1 agonist Ozempic (semaglutide) - are peptide therapies, demonstrating the profound clinical power of these compounds.

2026 Regulatory Deep Dive

2026 Status Report: While Secretary RFK Jr. stated on Feb 27, 2026, that the FDA is considering moving ~14 peptides back to Category 1 status 'within weeks,' no official HHS press release has been finalized.

Key Impacted Peptides: BPC-157, TB-500, Thymosin Alpha-1, CJC-1295, Ipamorelin, AOD-9604, Selank, Semax, MOTS-C, KPV, and GHK-Cu.

Important Nuance: Even if reclassified, these remain non-FDA-approved compounds requiring a physician's prescription and preparation by licensed 503A compounding pharmacies.

US & Canada Peptide Regulatory Status

Last Updated: March 2026

Peptide US (FDA) Status Canada (Health Canada) Status
AOD-9604 Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
BPC-157 Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
CJC-1295 Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
Epitalon Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
GHK-Cu (Injectable) Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
Ipamorelin Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
Kisspeptin-10 Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
KPV Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
Melanotan II Category 2 - Restricted Health Canada Agile Licensing Review (March 2026)
MOTS-C Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
Selank Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
Semax Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
Thymosin Alpha-1 Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)
Thymosin Beta-4 (TB-500) Category 1 (March 2026 - Restored for Compounding) Health Canada Agile Licensing Review (March 2026)

Quick-Start Targeting Matrix: Most Commonly Researched Peptides

Categorized by primary research goal

Primary Goal Common Peptides
Healing & Recovery BPC-157 TB-500
Fat Loss & Metabolism AOD-9604 MOTS-C
Growth Hormone Secretagogues CJC-1295 Ipamorelin
Immunity & Inflammation Thymosin Alpha-1 KPV
Longevity & Anti-Aging Epitalon GHK-Cu
Cognitive & Nootropic Selank Semax
Libido & Pigmentation Melanotan II
Hormonal Balance Kisspeptin-10

For Educational & Research Purposes Only. Not Medical Advice.

Live Research Search

Note: The Europe PMC database pulls directly from US PubMed, MEDLINE, and international grants.

Explore Key Peptides: BPC-157, TB-500, AOD-9604, MOTS-C, CJC-1295, Ipamorelin, Thymosin Alpha-1, Epitalon, Selank, Semax, GHK-Cu, Melanotan II, KPV, Kisspeptin-10
Research Paper Title Focus Area Year Key Takeaway Action
Therapeutic Peptides: Current Applications
Wang et al.
General applications and advancements in improving Bioavailability. 2022 Reviews how chemical modifications have overcome classical shortcomings, leading to expanded Subcutaneous and oral options. View Full Text
Trends in Peptide Drug Discovery
Muttenthaler et al.
New molecular design trends shaping the next decade. 2021 Highlights the resurgence in peptide drug discovery powered by new formulation strategies. View Full Text

Verified Health & Longevity Partners

Elevate HER Logo
Expert Adviser

Dr. Rosanne Woods, PhD

University Professor & Multi-Time Award-Winning Fitness Trainer

Dr. Woods bridges the gap between clinical research and practical application, ensuring evidence-based protocols drive this portal's standard of excellence.

Visit Website
CNC
Synthesis Partner

CNC Bio Labs

High-Purity API Manufacturing

Clinical-grade peptide synthesis and research compounds. Setting the industry standard for precision manufacturing and third-party analytical testing.

Explore Compounds